BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29568092)

  • 1. Prognostic significance of interphase FISH in monoclonal gammopathy of undetermined significance.
    Lakshman A; Paul S; Rajkumar SV; Ketterling RP; Greipp PT; Dispenzieri A; Gertz MA; Buadi FK; Lacy MQ; Dingli D; Fonder AL; Hayman SR; Hobbs MA; Gonsalves WI; Hwa YL; Kapoor P; Leung N; Go RS; Lin Y; Kourelis TV; Warsame R; Lust JA; Russell SJ; Zeldenrust SR; Kyle RA; Kumar SK
    Leukemia; 2018 Aug; 32(8):1811-1815. PubMed ID: 29568092
    [No Abstract]   [Full Text] [Related]  

  • 2. Interphase fluorescence in situ hybridization in multiple myeloma and monoclonal gammopathy of undetermined significance without and with positive plasma cell identification: analysis of 192 cases from the Region of Southern Denmark.
    Christensen JH; Abildgaard N; Plesner T; Nibe A; Nielsen O; Sørensen AG; Kerndrup GB;
    Cancer Genet Cytogenet; 2007 Apr; 174(2):89-99. PubMed ID: 17452249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interphase fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significance.
    Drach J; Angerler J; Schuster J; Rothermundt C; Thalhammer R; Haas OA; Jäger U; Fiegl M; Geissler K; Ludwig H; Huber H
    Blood; 1995 Nov; 86(10):3915-21. PubMed ID: 7579361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct and shared three-dimensional chromosome organization patterns in lymphocytes, monoclonal gammopathy of undetermined significance and multiple myeloma.
    Sathitruangsak C; Righolt CH; Klewes L; Tung Chang D; Kotb R; Mai S
    Int J Cancer; 2017 Jan; 140(2):400-410. PubMed ID: 27711972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma.
    Mikulasova A; Wardell CP; Murison A; Boyle EM; Jackson GH; Smetana J; Kufova Z; Pour L; Sandecka V; Almasi M; Vsianska P; Gregora E; Kuglik P; Hajek R; Davies FE; Morgan GJ; Walker BA
    Haematologica; 2017 Sep; 102(9):1617-1625. PubMed ID: 28550183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of cytogenetics and in situ hybridization to the study of monoclonal gammopathies of undetermined significance.
    Lloveras E; Solé F; Florensa L; Besses C; Espinet B; Gil M; Pérez-Vila ME; Pedro C; Abella E; Sans-Sabrafen J; Woessner S
    Cancer Genet Cytogenet; 2002 Jan; 132(1):25-9. PubMed ID: 11801304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant increase of CKS1B amplification from monoclonal gammopathy of undetermined significance to multiple myeloma and plasma cell leukaemia as demonstrated by interphase fluorescence in situ hybridisation.
    Chang H; Yeung J; Xu W; Ning Y; Patterson B
    Br J Haematol; 2006 Sep; 134(6):613-5. PubMed ID: 16889615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical features and prognosis of the monoclonal gammopathy undetermined significance: A single center study.
    Ma L; Xu S; Wen L; Liu Y; Kang Y; Huang X; Lu J
    Blood Cells Mol Dis; 2018 Nov; 73():9-13. PubMed ID: 30195627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of cytogenetically abnormal plasma cells in light chain amyloidosis and their prognostic relevance.
    Kim SY; Im K; Park SN; Kim JA; Yoon SS; Lee DS
    Leuk Res; 2016 May; 44():45-52. PubMed ID: 27015231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperdiploidy is a common finding in monoclonal gammopathy of undetermined significance and monosomy 13 is restricted to these hyperdiploid patients.
    Brousseau M; Leleu X; Gerard J; Gastinne T; Godon A; Genevieve F; Dib M; Lai JL; Facon T; Zandecki M;
    Clin Cancer Res; 2007 Oct; 13(20):6026-31. PubMed ID: 17947464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instability.
    Bochtler T; Hegenbart U; Cremer FW; Heiss C; Benner A; Hose D; Moos M; Bila J; Bartram CR; Ho AD; Goldschmidt H; Jauch A; Schonland SO
    Blood; 2008 May; 111(9):4700-5. PubMed ID: 18305218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma.
    Oliva S; De Paoli L; Ruggeri M; Caltagirone S; Troia R; Oddolo D; D'Agostino M; Gilestro M; Mina R; Saraci E; Margiotta Casaluci G; Genuardi E; Bringhen S; Boccadoro M; Omedé P
    Ann Hematol; 2021 Feb; 100(2):437-443. PubMed ID: 33392702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic abnormalities in monoclonal gammopathy of undetermined significance.
    Merz M; Hielscher T; Hoffmann K; Seckinger A; Hose D; Raab MS; Hillengass J; Jauch A; Goldschmidt H
    Leukemia; 2018 Dec; 32(12):2717-2719. PubMed ID: 29977018
    [No Abstract]   [Full Text] [Related]  

  • 14. MYD88 (L265P) mutation is an independent risk factor for progression in patients with IgM monoclonal gammopathy of undetermined significance.
    Varettoni M; Zibellini S; Arcaini L; Boveri E; Rattotti S; Pascutto C; Mangiacavalli S; Gotti M; Pochintesta L; Paulli M; Cazzola M
    Blood; 2013 Sep; 122(13):2284-5. PubMed ID: 24072850
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma cell enrichment enhances detection of high-risk cytogenomic abnormalities by fluorescence in situ hybridization and improves risk stratification of patients with plasma cell neoplasms.
    Lu G; Muddasani R; Orlowski RZ; Abruzzo LV; Qazilbash MH; You MJ; Wang Y; Zhao M; Chen S; Glitza IC; Medeiros LJ
    Arch Pathol Lab Med; 2013 May; 137(5):625-31. PubMed ID: 23627452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of chromosomal aberrations in lung tissue and peripheral blood lymphocytes using interphase fluorescence in situ hybridization (FISH).
    el-Zein RA; Abdel-Rahman SZ
    Methods Mol Med; 2003; 75():145-61. PubMed ID: 12407739
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantitative analysis of CKS1B mRNA expression and copy number gain in patients with plasma cell disorders.
    Stella F; Pedrazzini E; Baialardo E; Fantl DB; Schutz N; Slavutsky I
    Blood Cells Mol Dis; 2014 Sep; 53(3):110-7. PubMed ID: 24973170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of immunoglobulin light chain gene aberrations as revealed by FISH in multiple myeloma and MGUS.
    Türkmen S; Binder A; Gerlach A; Niehage S; Theodora Melissari M; Inandiklioglu N; Dörken B; Burmeister T
    Genes Chromosomes Cancer; 2014 Aug; 53(8):650-6. PubMed ID: 24729354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
    Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
    Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention Is the Best Treatment: The Case for Understanding the Transition from Monoclonal Gammopathy of Undetermined Significance to Myeloma.
    Tomasson MH; Ali M; De Oliveira V; Xiao Q; Jethava Y; Zhan F; Fitzsimmons AM; Bates ML
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30453544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.